SAIMSARA Journal

Machine Generated Science • ISSN 3054-3991

Guarana and Health: Scoping Review with ☸️SAIMSARA.

Longevity icon

Longevity

Issue 2, Volume 1, 2026

Editorial note
• Last update: 2026-03-29 11:00:51
What is this paper about
This paper shows that guarana is more than an energy-drink stimulant: across human, animal, and laboratory evidence it emerges as a biologically active compound with signals in cognition, metabolism, fatigue, and oxidative stress, but with clear safety concerns when pushed into high-stimulant or mixed-product use. The full read is worth it because it separates where guarana itself looks genuinely promising, where the signal comes mainly from guarana-containing formulations, and where the real clinical and toxicologic limits begin.

DOI: 10.62487/saimsarab08b44a9

Abstract: The aim of this review is to synthesize the current scientific literature regarding the biological activities, clinical efficacy, and safety profile of guarana across human, animal, and in vitro models. The review utilises 167 original studies with 251199 total participants (topic deduplicated ΣN). The evidence map suggests that guarana has its clearest human signals in acute cognitive performance and metabolic regulation, alongside notable safety concerns at higher stimulant exposures. In particular, guarana-containing interventions were associated with body fat reductions of 5.53% at 4 weeks and 15.6% at 12 weeks in one formulation study, while delayed gastric emptying and weight loss of about 5.1 kg over 45 days were reported in overweight adults using a South American herbal preparation. Across experimental and translational studies, these effects are supported by a plausible mechanistic profile involving methylxanthines, polyphenols, antioxidant activity, adipogenesis inhibition, and modulation of lipid and carbohydrate metabolism. Clinically, this supports a potential role for guarana in short-term cognitive support, exercise-related performance, and selected fatigue or weight-management settings, but also reinforces the need for caution in people at cardiovascular or neurologic risk because serious adverse events have been reported with guarana-containing stimulant products. The next phase of research should prioritize standardized guarana-only preparations, dose-ranging pharmacokinetic and safety studies, and adequately powered longer-term randomized trials that can distinguish guarana-specific benefits from those of caffeine and multi-ingredient formulations.

Keywords: Paullinia cupana; Cognitive performance; Antioxidant activity; Metabolomic profiling; Anti-adipogenic potential; Neuroprotective effects; Lipid metabolism; Physical performance; Oxidative stress; Cytotoxicity

Review Stats

Get access to the full paper

temporary link or permanent access.

The remaining part of the paper opens after purchase or unlock.

Reference Index (161)